March 16, 2017 / 2:28 PM / 4 months ago

BRIEF-Histogenics Corporation Q4 loss per share $0.63

1 Min Read

March 16 (Reuters) - Histogenics Corp

* Histogenics Corporation announces financial and operating results for the fourth quarter and year ended December 31, 2016

* Histogenics Corp qtrly loss per share $0.63

* Histogenics Corp says financing completed in Q3 of 2016 expected to fund company to phase 3 data

* Histogenics Corp - intends to complete raw materials engineering runs in 2017 including generating data for collagen scaffold and proprietary adhesive

* Histogenics - at December 31, 2016, had cash, cash equivalents and marketable securities of $31.9 million, compared to $30.9 million at December 31, 2015

* Histogenics - expects total operating expenses of between $25 and $27 million for year ended December 31, 2017

* Histogenics - believes its current cash position will be sufficient to fund its operations into middle of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below